The lymphocyte function associated antigen-1 (LFA-1) is evaluated for a targeting carrier in leukemia. The cIBR peptide was utilized as the targeting moiety for the drug carrier in direct targeting to LFA-1 expressing cancer cells. This study aims to evaluate the effects of the cIBR peptide conjugation on the specific targeting delivery to the leukemic cell line. Poly (D, L lactide-co-glycolide) (PLGA) nanoparticles were conjugated to the cIBR peptide by three different approaches (coupling, head, and tail) in order to evaluate the nanoparticles' characters, targetability, uptake, drug releasing, and cytotoxicity of each approach. The prepared PLGA nanoparticles were spherical lin shape with a size range of 200–450 nm. The targetability and uptake of three types of cIBR-conjugated nanoparticles (cIBR-NPs) were evidenced and quantified by flow cytometry. The coupling approach presented the highest targetability, uptake, drug releasing, and cytotoxicity followed by the head and tail approaches, respectively. The peptide conjugation method onto the nanoparticles surface was proven to be a key factor for the nanoparticles' physicochemical characteristicss and their efficient delivery.
Issue Section:
Research Papers
References
1.
Cho
, K.
, Wang
, X.
, Nie
, S.
, and Shin
, D. M.
, 2008
, “Therapeutic Nanoparticles for Drug Delivery in Cancer
,” Clin. Cancer. Res.
, 14
(5
), pp. 1310
–1316
.10.1158/1078-0432.CCR-07-14412.
Das
, M.
, Mohanty
, C.
, and Sahoo
, S. K.
, 2009
, “Ligand-Based Targeted Therapy for Cancer Tissue
,” Expert Opin. Drug Deliv.
, 6
(3
), pp. 285
–304
.10.1517/174252409027801663.
Danhier
, F.
, Feron
, O.
, and Préat
, V.
, 2010
, “To Exploit the Tumor Microenvironment: Passive and Active Tumor Targeting of Nanocarriers for Anti-Cancer Drug Delivery
,” J. Controlled Release
, 148
(2
), pp. 135
–146
.10.1016/j.jconrel.2010.08.0274.
Gantert
, M.
, Lewrick
, F.
, Adrian
, J. E.
, Rössler
, J.
, Steenpaß
, T.
, Schubert
, R.
, and Peschka-Süss
, R.
, 2009
, “Receptor-Specific Targeting With Liposomes In Vitro Based on Sterol-PEG 1300 Anchors
,” Pharm. Res.
, 26
(3
), pp. 529
–538
.10.1007/s11095-008-9768-z5.
Liu
, P.
, Wang
, H.
, Wang
, Q.
, Sun
, Y.
, Shen
, M.
, Zhu
, M.
, Wan
, Z.
, and Duan
, Y. J.
, 2012
, “cRGD Conjugated mPEG-PLGA-PLL Nanoparticles for SGC-7901 Gastric Cancer Cells—Targeted Delivery of Fluorouracil
,” J. Nanosci. Nanotechnol.
, 12
(6
), pp. 4467
–4471
.10.1166/jnn.2012.62136.
Gu
, H.
, Zheng
, R.
, Zhang
, X. X.
, and Xu
, B.
, 2004
, “Facile One-Pot Synthesis of Bifunctional Heterodimers of Nanoparticles: A Conjugate of Quantum Dot and Magnetic Nanoparticles
,” J. Am. Chem. Soc.
, 126
(18
), pp. 5664
–5665
.10.1021/ja04964237.
Mohanraj
, V.
, and Chen
, Y.
, 2007
, “Nanoparticles—A Review
,” Trop. J. Pharm. Res.
, 5
(1
), pp. 561
–573
.10.4314/tjpr.v5i1.146348.
Kuo
, J. W.
, Swann
, D. A.
, and Prestwich
, G. D.
, 1991
, “Chemical Modification of Hyaluronic Acid by Carbodiimides
,” Bioconjugate. Chem.
, 2
(4
), pp. 232
–241
.10.1021/bc00010a0079.
Liebmann
, J.
, Cook
, J.
, Lipschultz
, C.
, Teague
, D.
, Fisher
, J.
, and Mitchell
, J.
, 1993
, “Cytotoxic Studies of Paclitaxel (Taxol) in Human Tumour Cell Lines
,” Brit. J. Cancer
, 68
(6
), pp. 1104–1109
.10.1038/bjc.1993.48810.
Kuppens
, I.
, 2006
, “Current State of the Art of New Tubulin Inhibitors in the Clinic
,” Curr. Clin. Pharm.
, 1
(1
), pp. 57
–70
.10.2174/15748840677526820011.
Phongpradist
, R.
, Chittasupho
, C.
, Okonogi
, S.
, Siahaan
, T.
, Anuchapreeda
, S.
, Ampasavate
, C.
, and Berkland
, C.
, 2010
, “LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery
,” Curr. Pharm. Des.
, 16
(21
), pp. 2321
–2330
.10.2174/13816121079192045012.
Chittasupho
, C.
, Shannon
, L.
, Siahaan
, T. J.
, Vines
, C. M.
, and Berkland
, C.
, 2011
, “Nanoparticles Targeting Dendritic Cell Surface Molecules Effectively Block T Cell Conjugation and Shift Response
,” ACS Nano
, 5
(3
), pp. 1693
–1702
.10.1021/nn102159g13.
Chittasupho
, C.
, Xie
, S.
, Baoum
, A.
, Yakovleva
, T.
, Siahaan
, T.
, and Berkland
, C.
, 2009
, “ICAM-1 Targeting of Doxorubicin-Loaded PLGA Nanoparticles to Lung Epithelial Cells
,” Eur. J. Pharm. Sci.
, 37
(2
), pp. 141
–150
.10.1016/j.ejps.2009.02.00814.
Mukerjee
, A.
, and Vishwanatha
, J.
, 2009
, “Formulation, Characterization and Evaluation of Curcumin-Loaded PLGA Nanospheres for Cancer Therapy
,” Anticancer. Res.
, 29
(10
), pp. 38
–67
.15.
Chittasupho
, C.
, Manikwar
, P.
, Krise
, J.
, Siahaan
, T.
, and Berkland
, C.
, 2010
, “cIBR Effectively Targets Nanoparticles to LFA-1 on Acute Lymphoblastic T Cells
,” Mol. Pharmaeutics.
, 7
(1
), pp. 146
–155
10.1021/mp900185u.16.
Benner
, S. A.
, and Eyler
, R.
, 1996
, “Analysis of Combinatorial Libraries Using Electrospray Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
,” Rapid. Commun. Mass Spectrom.
, 10
, pp. 1860
–1864
.10.1002/(SICI)1097-0231(199611)10:14<1860::AID-RCM770>3.0.CO;2-#17.
Lim
, H. J.
, Nam
, H. Y.
, Lee
, B. H.
, Kim
, D. J.
, Ko
, J. Y.
, and Park
, J.
, 2007
, “A Novel Technique for Loading of Paclitaxel-PLGA Nanoparticles Onto ePTFE Vascular Grafts
,” Biotechnol. Prog.
, 23
(3
), pp. 693
–697
.10.1021/bp060338i18.
Bojat
, V.
, Balabanyan
, V.
, and Alyautdin
, R.
, 2011
, “The Entrapment of Paclitaxel in PLGA Nanoparticles Increases Its Cytotoxicity Against Multiresistant Cell Line
,” Brit. J. Med. Med. Res.
, 1
(4
), pp. 306
–319
.19.
Yokoyama
, M.
, 2005
, “Drug Targeting With Nano-Sized Carrier Systems
,” J. Artif. Organs.
, 8
(2
), pp. 77
–84
.10.1007/s10047-005-0285-020.
Dinarv
, R.
, Sepehri
, N.
, Manoochehri
, S.
, Rouhani
, H.
, and Atyabi
, F.
, 2011
, “Polylactide-co-glycolide Nanoparticles for Controlled Delivery of Anticancer Agents
,” Int. J. Nanomedicine
, 6
, pp. 877
–895
.10.2147/IJN.S1890521.
Peer
, D.
, Karp
, J.
, Hong
, S.
, Farokhzad
, O.
, Margalit
, R.
, and Langer
, R.
, 2007
, “Nanocarriers as an Emerging Platform for Cancer Therapy
,” Nat. Nanotechnol.
, 2
(12
), pp. 751
–760
.10.1038/nnano.2007.38722.
Mainardes
, R. M.
, and Evangelista
, R. C.
, 2005
, “PLGA Nanoparticles Containing Praziquantel: Effect of Formulation Variables on Size Distribution
,” Int. J. Pharm.
, 290
(1
), pp. 137
–144
.10.1016/j.ijpharm.2004.11.02723.
Kempen
, D. H. R.
, Lu
, L.
, Zhu
, X.
, Kim
, C.
, Jabbari
, E.
, Dhert
, W. J. A.
, Currier
, B. L.
, and Yaszemski
, M. J.
, 2004
, “Development of Biodegradable Poly (Propylene Fumarate)/Poly (Lactic-Co-Glycolic Acid) Blend Microspheres. I. Preparation and Characterization
,” J. Biomed. Mater. Res.
, 70
(2
), pp. 283
–292
.10.1002/jbm.a.3007924.
Sahana
, B.
, Santra
, K.
, Basu
, S.
, and Mukherjee
, B.
, 2010
, “Development of Biodegradable Polymer Based Tamoxifen Citrate Loaded Nanoparticles and Effect of Some Manufacturing Process Parameters on Them: A Physicochemical and In-Vitro Evaluation
,” Int. J. Nanomedicine
, 5
, pp. 621
–630
10.2147/IJN.S9962.25.
Makadia
, H. K.
, and Siegel
, S. J.
, 2011
, “Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
,” Polymers
, 3
(3
), pp. 1377
–1397
.10.3390/polym303137726.
Faisant
, N.
, Siepmann
, J.
, and Benoit
, J. P.
, 2002
, “PLGA-Based Microparticles: Elucidation of Mechanisms and a New, Simple Mathematical Model Quantifying Drug Release
,” Eur. J. Pharm. Sci.
, 15
(4
), pp. 355
–366
.10.1016/S0928-0987(02)00023-427.
Kilic
, M. A.
, Ozlu
, E.
, and Calis
, S.
, 2012
, “A Novel Protein-Based Anticancer Drug Encapsulating Nanosphere
,” J. Biomed. Nanotechnol.
, 8
(3
), pp. 508
–514
.10.1166/jbn.2012.140628.
Warren
, R. A.
, Green
, F. A.
, and Enns
, C. A.
, 1997
, “Saturation of the Endocytic Pathway for the Transferrin Receptor Does Not Affect the Endocytosis of the Epidermal Growth Factor Receptor
,” J. Biol. Chem.
, 272
(4
), pp. 2116
–2121
.10.1074/jbc.272.4.211629.
Phongpradist
, R.
, Chiampanichayakul
, S.
, Tima
, S.
, Siahaan
, T. J.
, Berkland
, C. J.
, Anuchapreeda
, S.
, and Ampasavate
, C.
, 2012
, “Potential cIBR-Conjugated PLGA Nanoparticles for Selective Targeting to Leukemic Cells
,” Waset. org
, 6
(6
), pp. 252
–260
.Copyright © 2013 by ASME
You do not currently have access to this content.
